RecruitingNCT07040332
Pathogenesis and Inflammatory Phenotype of Allergic Bronchopulmonary Aspergillosis
Sponsor
Qianfoshan Hospital
Enrollment
140 participants
Start Date
May 10, 2025
Study Type
OBSERVATIONAL
Conditions
Summary
This study aims to reveal the immune and inflammatory regulatory molecular mechanisms related to the progression of allergic bronchopulmonary aspergillosis (ABPA), and to build a precision typing based on inflammation and identify the biomarkers of typing, and to explore the clinical outcomes of different inflammatory phenotypes.
Eligibility
Min Age: 18 Years
Inclusion Criteria2
- Meets the diagnostic criteria for allergic bronchopulmonary aspergillosis.
- Meets the diagnostic criteria for fungal-sensitized asthma.
Exclusion Criteria8
- Human immunodeficiency virus infection.
- Malignant tumor.
- Blood system disease.
- autoimmune system disease.
- History of pulmonary tuberculosis.
- Patients with a history of smoking or still smoking.
- Invasive pulmonary fungal disease.
- Contraindications electronic bronchoscopy
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHER
No intervention
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07040332
Related Trials
A Cohort Study of the Efficacy and Safety of Biologics in Patients With ABPA
NCT073626931 location
Immune Status and Disease Control of Inflammatory Airway Diseases
NCT074936291 location
A Study of the Efficacy and Safety of Bronchoscopic Airway Clearance and Amphotericin B Spraying in Patients With ABPA
NCT073626671 location